SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-071361
Filing Date
2023-03-15
Accepted
2023-03-15 16:27:27
Documents
6
Effectiveness Date
2023-03-15

Document Format Files

Seq Description Document Type Size
1 S-8 d470373ds8.htm S-8 40630
2 EX-5.1 d470373dex51.htm EX-5.1 12169
3 EX-23.2 d470373dex232.htm EX-23.2 1784
4 EX-FILING FEES d470373dexfilingfees.htm EX-FILING FEES 18700
5 GRAPHIC g470373g0315233040789.jpg GRAPHIC 1843
6 GRAPHIC g470373g0315233508356.jpg GRAPHIC 2345
  Complete submission text file 0001193125-23-071361.txt   80595
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270566 | Film No.: 23735590
SIC: 2836 Biological Products, (No Diagnostic Substances)